This report contains market size and forecasts of Antisense Oligonucleotide (ASO) Therapeutics in Global, including the following market information:
Global Antisense Oligonucleotide (ASO) Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antisense Oligonucleotide (ASO) Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pulmonary Delivery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antisense Oligonucleotide (ASO) Therapeutics include Ionis Pharmaceuticals, Inc, Sarpeta Therapeutics Inc., Biogen Inc, Alnylam Pharmaceuticals, Inc, Antisense Therapeutics Limited, Arrowhead Pharmaceuticals Inc., Enzon Pharmaceuticals, Inc., Bio-Path Holdings, Inc. and GlaxoSmithKline PLC and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antisense Oligonucleotide (ASO) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antisense Oligonucleotide (ASO) Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antisense Oligonucleotide (ASO) Therapeutics Market Segment Percentages, by Type, 2021 (%)
Pulmonary Delivery
Intravenous Injections
Intradermal Injections
Intraperitoneal Injections
Topical Delivery
Others
Global Antisense Oligonucleotide (ASO) Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antisense Oligonucleotide (ASO) Therapeutics Market Segment Percentages, by Application, 2021 (%)
Genetic Disorders
Neurological Disorders
Oncological Disorders
Metabolic Disorders
Ophthalmic Disorders
Others
Global Antisense Oligonucleotide (ASO) Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antisense Oligonucleotide (ASO) Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antisense Oligonucleotide (ASO) Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antisense Oligonucleotide (ASO) Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ionis Pharmaceuticals, Inc
Sarpeta Therapeutics Inc.
Biogen Inc
Alnylam Pharmaceuticals, Inc
Antisense Therapeutics Limited
Arrowhead Pharmaceuticals Inc.
Enzon Pharmaceuticals, Inc.
Bio-Path Holdings, Inc.
GlaxoSmithKline PLC
Geron Corporation (Geron)